The University of Chicago Header Logo

Connection

Jason X. Cheng to Bevacizumab

Back to Details
This is a "connection" page, showing publications Jason X. Cheng has written about Bevacizumab.
Jason X. Cheng
Connection Strength
0.112
Bevacizumab
  1. Neoadjuvant bevacizumab and chemoradiotherapy in locally advanced rectal cancer: early outcome and technical impact on toxicity. World J Surg Oncol. 2014 Nov 06; 12:329.
    View in: PubMed
    Score: 0.112
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.